EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Reduced Serum Urate Concentrations Despite Unchanged Allopurinol Dosing in Gout Patients Commenced on Dialysis: A Retrospective Chart Review

Noha Kamel iD, Ronald Castelino iD, Daniel Wright iD, Kamal Sud iD, Surjit Tarafdar iD, Stephen Hughes iD, Sophie Stocker iD

Nephrology · 2026-03 · 31 (3)

DOI: 10.1111/nep.70184 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nephrology, online erschienen am 13.03.2026. Verfasst von Noha Kamel und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Faculty of Medicine & Health, The University of Sydney, New South Wales, Australia. Hauptthemen laut MEDLINE: Allopurinol, Gout, Renal Dialysis, Uric Acid. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

People with kidney failure are at increased risk of gout‐related hospitalisations and mortality. Whilst dialysis enhances urate removal and reduces circulating oxypurinol (allopurinol's active metabolite), its effect on achieving target serum urate concentrations (< 0.36 mmol/L) and implications for gout management remain unclear. This study aimed to evaluate serum urate concentrations and allopurinol dosing following commencement of dialysis.

Methods

We conducted a retrospective chart review of adults prescribed allopurinol at a dialysis Centre in New South Wales, Australia, between 01/06/2019 and 30/06/2024. Eligible patients had at least one serum urate concentration recorded after commencing dialysis. Data collected included patient demographics, dialysis modality, allopurinol dosing, and serum urate concentrations, spanning from pre‐dialysis to up to 5 years post‐commencing dialysis.

Results

Forty‐five patients (18 haemodialysis [HD], 27 peritoneal dialysis [PD]) were included. Most HD patients (61%) received thrice‐weekly haemodiafiltration with high‐flux dialysers; 59% of PD patients used automated PD. Allopurinol doses (100–300 mg daily, mostly 100 mg) remained unchanged from pre‐dialysis in 93% (42/45). At 4 (0.25–38) months post‐dialysis, median serum urate concentrations declined compared to pre‐commencing dialysis (HD: 0.31 vs. 0.51 mmol/L, p = 0.031; PD: 0.33 vs. 0.53 mmol/L, p < 0.001). Target serum urate concentrations were reached at least once in 60% of HD and 78% of PD patients.

Conclusion

Serum urate concentrations declined after starting dialysis with unchanged allopurinol dosing, suggesting dialysis independently contributes to urate reduction. These findings support re‐evaluating allopurinol dose in patients after commencing dialysis, including de‐prescribing allopurinol in those who consistently achieve target urate concentrations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AllopurinolGoutRenal DialysisUric AcidGout SuppressantsKidney Failure, ChronicHumansRetrospective StudiesFemaleMaleMiddle AgedAgedNew South Wales

Stichwörter der Autor:innen

allopurinolgouthaemodialysisperitoneal dialysisuric acid

Substanzen

AllopurinolUric AcidGout Suppressants

Autor:innen und Institutionen

  • School of Pharmacy, Faculty of Medicine & Health, The University of Sydney, New South Wales, Australia.
  • Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt.
  • Pharmacy Department, Blacktown Hospital, Sydney, New South Wales, Australia.
  • Department of Clinical Pharmacology and Toxicology, St Vincent's Hospital Sydney, Sydney, New South Wales, Australia.
  • St. Vincent's Clinical School, Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia.
  • Nepean Clinical School, The University of Sydney, Sydney, New South Wales, Australia.

ORCID-Profile: Noha Kamel, Ronald Castelino, Daniel Wright, Kamal Sud, Surjit Tarafdar, Stephen Hughes, Sophie Stocker

Zitieren

APA

Kamel, N., Castelino, R., Wright, D., Sud, K., Tarafdar, S., Hughes, S., & Stocker, S. (2026). Reduced Serum Urate Concentrations Despite Unchanged Allopurinol Dosing in Gout Patients Commenced on Dialysis: A Retrospective Chart Review. Nephrology, 31(3). https://doi.org/10.1111/nep.70184

Vancouver

Kamel N, Castelino R, Wright D, Sud K, Tarafdar S, Hughes S, et al. Reduced Serum Urate Concentrations Despite Unchanged Allopurinol Dosing in Gout Patients Commenced on Dialysis: A Retrospective Chart Review. Nephrology. 2026;31(3). doi:10.1111/nep.70184

BibTeX
@article{Kamel2026,
  author = {Kamel, Noha and Castelino, Ronald and Wright, Daniel and Sud, Kamal and Tarafdar, Surjit and Hughes, Stephen and Stocker, Sophie},
  title = {Reduced Serum Urate Concentrations Despite Unchanged Allopurinol Dosing in Gout Patients Commenced on Dialysis: A Retrospective Chart Review},
  journal = {Nephrology},
  year = {2026},
  volume = {31},
  number = {3},
  doi = {10.1111/nep.70184}
}
Kostenlos starten →